Acetohexamide
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 317155

CAS#: 968-81-0

Description: Acetohexamide is a sulfonylurea derivative. Acetohexamide is a hyopglycemic agent with moderate uricosuric activity. Acetohexamide is a first generation medication used in the treatment of diabetes metilus type 2.


Price and Availability

Size
Price

50mg
USD 70
500mg
USD 150
5g
Ask price
50g
Ask price
Size
Price

100mg
USD 90
1g
USD 250
10g
Ask price
Size
Price

200mg
USD 120
2g
USD 450
20g
Ask price

Acetohexamide, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 317155
Name: Acetohexamide
CAS#: 968-81-0
Chemical Formula: C15H20N2O4S
Exact Mass: 324.11438
Molecular Weight: 324.4
Elemental Analysis: C, 55.54; H, 6.21; N, 8.64; O, 19.73; S, 9.88


Synonym: Acetohexamide; Dymelor; Gamadiabet; Acetohexamid; Dimelin; Dimelor

IUPAC/Chemical Name: 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea

InChi Key: VGZSUPCWNCWDAN-UHFFFAOYSA-N

InChi Code: InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)

SMILES Code: CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Aldawsari H, Altaf A, Banjar ZM, Iohara D, Nakabayashi M, Anraku M, Uekama K, Hirayama F. Crystallization of a new polymorph of acetohexamide from 2-hydroxybutyl-β-cyclodextrin solution: form VI with a high aqueous solubility. Int J Pharm. 2013 Sep 10;453(2):315-21. doi: 10.1016/j.ijpharm.2013.06.026. Epub 2013 Jun 21. PubMed PMID: 23796835.

2: Kretschy N, Teichmann M, Kopf S, Atanasov AG, Saiko P, Vonach C, Viola K, Giessrigl B, Huttary N, Raab I, Krieger S, Jäger W, Szekeres T, Nijman SM, Mikulits W, Dirsch VM, Dolznig H, Grusch M, Krupitza G. In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen. Br J Cancer. 2013 Feb 19;108(3):570-8. doi: 10.1038/bjc.2012.580. Epub 2013 Jan 8. PubMed PMID: 23299527; PubMed Central PMCID: PMC3593542.

3: Joseph KS, Anguizola J, Jackson AJ, Hage DS. Chromatographic analysis of acetohexamide binding to glycated human serum albumin. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 15;878(28):2775-81. doi: 10.1016/j.jchromb.2010.08.021. Epub 2010 Aug 21. PubMed PMID: 20829128; PubMed Central PMCID: PMC2952882.

4: Tokunaga H, Uchino T. [Studies for analyzing the prohibited ingredients such as acetohexamide in cosmetics]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2005;(123):19-22. Japanese. PubMed PMID: 16541746.

5: Imamura Y, Shimada H. Differential pharmacokinetics of acetohexamide in male Wistar-Imamichi and Sprague-Dawley rats: role of microsomal carbonyl reductase. Biol Pharm Bull. 2005 Jan;28(1):185-7. PubMed PMID: 15635190.

6: Imamura Y, Kaneko M, Takada H, Otagiri M, Shimada H, Akita H. Sex-dependent pharmacokinetics of S(-)-hydroxyhexamide, a pharmacologically active metabolite of acetohexamide, in rats. Comp Biochem Physiol C Toxicol Pharmacol. 2002 Dec;133(4):587-92. PubMed PMID: 12458186.

7: Shimada H, Yamaguchi S, Murata H, Otagiri M, Imamura Y. Cadmium exposure decreases androgen-dependent metabolism of acetohexamide in liver microsomes of male rats through its testicular toxicity. Arch Toxicol. 2002 Feb;76(1):8-12. Epub 2001 Dec 20. PubMed PMID: 11875619.

8: Imamura Y, Sanai K, Seri K, Akita H. Hypoglycemic effect of S(-)-hydroxyhexamide, a major metabolite of acetohexamide, and its enantiomer R(+)-hydroxyhexamide. Life Sci. 2001 Sep 7;69(16):1947-55. PubMed PMID: 11693275.

9: Imamura Y, Uchida A, Takada H, Otagiri M, Tsuchiya K. [Strain-, sex- and species-related differences of acetohexamide reductase and 20 beta-hydroxysteroid dehydrogenase activities in liver microsomes of experimental animals]. Yakugaku Zasshi. 2001 Jan;121(1):85-91. Japanese. PubMed PMID: 11201165.

10: Imamura Y, Koga T, Uriu Y, Otagiri M, Satoh K, Hara A. Catalytic properties for naphthoquinones and partial primary structure of rabbit heart acetohexamide reductase. Biol Pharm Bull. 2000 Feb;23(2):155-8. PubMed PMID: 10706377.